Clinical Trial Results:
A randomized phase II trial exploring feasibility of densification and optimal sequencing of postoperative adjuvant Fluorouracil, Epirubicin plus Cyclophosphamide (FEC) and Docetaxel chemotherapy in patients with high risk primary operable breast cancer.
Summary
|
|
EudraCT number |
2005-001876-11 |
Trial protocol |
BE |
Global completion date |
17 Aug 2007
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
05 Feb 2021
|
First version publication date |
05 Feb 2021
|
Other versions |
|
Summary report(s) |
2005-001876-11 Publicatie |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.